British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011

被引：695

作者：

Harris, Michael ^{[1
]}

Clark, Julia ^{[2
]}

Coote, Nicky ^{[3
]}

Fletcher, Penny ^{[4
]}

Harnden, Anthony ^{[5
]}

McKean, Michael ^{[6
]}

Thomson, Anne ^{[1
]}

机构：

[1] Oxford Childrens Hosp, Oxford OX3 9DU, England

[2] Great N Childrens Hosp, Royal Victoria Infirm, Dept Paediat Immunol & Infect Dis, Old COPD, Newcastle Upon Tyne, Tyne & Wear, England

[3] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Childrens Ambulatory Unit, London, England

[4] St Marys Hosp, Imperial Coll Healthcare NHS Trust, Dept Pharm, London, England

[5] Univ Oxford, Dept Primary Hlth Care, Oxford, England

[6] Royal Victoria Infirm, Dept Paediat Resp Med, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England

来源：

THORAX | 2011年 / 66卷

关键词：

PNEUMOCOCCAL CONJUGATE VACCINE; RESPIRATORY-TRACT INFECTIONS; RESISTANT STREPTOCOCCUS-PNEUMONIAE; POLYMERASE-CHAIN-REACTION; C-REACTIVE PROTEIN; RADIOGRAPHIC FOLLOW-UP; INFLUENZAE TYPE-B; MYCOPLASMA-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; ORAL AMOXICILLIN;

D O I：

10.1136/thoraxjnl-2011-200598

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

The British Thoracic Society first published management guidelines for community acquired pneumonia in children in 2002 and covered available evidence to early 2000. These updated guidelines represent a review of new evidence since then and consensus clinical opinion where evidence was not found. This document incorporates material from the 2002 guidelines and supersedes the previous guideline document.

引用

页码：II1 / II23

页数：23

共 200 条

[121] Pediatric respiratory infections by Mycoplasma pneumoniae
Lee, Kyung-Yil
[J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2008, 6 (04) : 509 - 521
[122] Lee PI, 2008, J MICROBIOL IMMUNOL, V41, P54
[123] LEVINE A, 1978, J AM OSTEOPATH ASSOC, V78, P122
[124] British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009
Lim, W. S.
Baudouin, S. V.
George, R. C.
Hill, A. T.
Jamieson, C.
Le Jeune, I.
Macfarlane, J. T.
Read, R. C.
Roberts, H. J.
Levy, M. L.
Wani, M.
Woodhead, M. A.
[J]. THORAX, 2009, 64 : 1 - 55
[125] Lin Chao-Jen, 2006, Journal of Microbiology Immunology and Infection, V39, P489
[126] Lin Pen-Yi, 2005, Chang Gung Med J, V28, P683
[127] What is the clinical impact of macrolide resistance?
Lonks J.R.
[J]. Current Infectious Disease Reports, 2004, 6 (1) : 7 - 12
[128] Oral versus i.v. antibiotics for community-acquired pneumonia in children: a cost-minimisation analysis
Lorgelly, P. K.
Atkinson, M.
Lakhanpaul, M.
Smyth, A. R.
Vyas, H.
Weston, V.
Stephenson, T.
[J]. EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (04) : 858 - 864
[129] Lu YJ, 2008, J MICROBIOL IMMUNOL, V41, P307
[130] Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age
Lucero, Marilla G.
Dulalia, Vernoni E.
Nillos, Leilani T.
Williams, Gail
Parrefio, Rhea Angela N.
Nohynek, Hanna
Riley, Ian D.
Makela, Helena
[J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04):

← 8 9 10 11 12 13 14 15 16 17 →